Cronos Group (CRON) Expands its Reach to Europe with a New Partnership

Cronos Group Inc. (NASDAQ:CRON) is one of the High Growth Penny Stocks That Are Profitable in 2025On July 2, Cronos Group Inc. (NASDAQ:CRON) announced expanding its reach in Europe by forging a new partnership with Dascoli Pharma AG.

Dascoli is a leader in distributing medical cannabis in Switzerland. As per the partnership, the company’s Peace Naturals medical cannabis flower will be sold through Dascoli’s Swiss network. The following strains of Peace Naturals would be available for patients in Switzerland, including GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. This partnership aligns with Cronos Group Inc. (NASDAQ:CRON)’s strategy to increase its presence in key medical cannabis markets.

Cronos Group (CRON) Expands its Reach to Europe with a New Partnership

A close up of cannabis plants growing in an outdoor facility, symbolizing the product of the cannabinoid company.

Cronos Group Inc. (NASDAQ:CRON) is a global cannabis company that develops and sells a variety of cannabinoid products.

While we acknowledge the potential of CRON to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CRON and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.